Literature DB >> 1852789

Clinical efficacy of clozapine in the treatment of schizophrenia.

H Y Meltzer1, L D Alphs, B Bastani, L F Ramirez, K Kwon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1852789

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN： 0176-3679            Impact factor:   5.788


× No keyword cloud information.
  5 in total

Review 1.  Smoking in schizophrenic patients: A critique of the self-medication hypothesis.

Authors:  Francesca Manzella; Susan E Maloney; George T Taylor
Journal:  World J Psychiatry       Date:  2015-03-22

2.  Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia.

Authors:  A Fitton; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

3.  Effect of clozapine upon schedule-induced polydipsia (SIP) resembles neither the actions of dopamine D1 nor D2 blockade.

Authors:  M Didriksen; G M Olsen; A V Christensen
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  T102C polymorphism of serotonin-2A receptor gene in Turkish schizophrenia patients: Association with cognitive impairment and soft neurological signs.

Authors:  Adnan Özçetin; Burç Çağrı Poyraz; Cana Aksoy Poyraz; Erol Bozhüyük; Nurullah Bolat; İbrahim Balcioğlu; Anıl Çağla Özkiliç; Zehra Seda Genç; Müjgan Cengiz
Journal:  Indian J Psychiatry       Date:  2014-10       Impact factor: 1.759

5.  Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis.

Authors:  Katharina Robichon; Vimal Patel; Bronwen Connor; Anne Camille La Flamme
Journal:  J Neuroinflammation       Date:  2020-02-12       Impact factor: 8.322
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.